Diseases
Major Reform for Rare Disease Treatments on the Horizon in UK
A new paper published by the Medicines and Healthcare products Regulatory Agency (MHRA) outlines a bold new approach to regulating rare disease therapies in the UK. The proposed reforms aim to speed up the development and approval of life-saving treatments for the estimated 3.5 million people living with a